Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP)

Abonnés: 0

Organisation

Health Canada | Santé Canada

Il n'y a pas de description pour cette organisation

Licence

ca-ogl-lgo

Activity type

db7b3e1b-b274-4c52-92e9-2a2a98b46cf1 created the jeu de données Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP)
il y a 3 mois

Newer activities Older activities